Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomised controlled trial to determine if statin therapy provides a beneficial anti-inflammatory effect in the management of persistent atopic asthma.

Trial Profile

A randomised controlled trial to determine if statin therapy provides a beneficial anti-inflammatory effect in the management of persistent atopic asthma.

Status: Completed
Phase of Trial: Phase III/IV

Latest Information Update: 02 Jul 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Simvastatin (Primary) ; Fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use

Most Recent Events

  • 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry record ACTRN12606000531516).
  • 29 Aug 2011 Planned initiation date (Feb 2007) added as reported by Australian New Zealand Clinical Trials Registry record.
  • 28 Jan 2011 Primary endpoint 'Additional-treatment-required' has not been met

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top